• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.用 DT-黄递酶诱导剂增强丝裂霉素 C 对人肿瘤细胞的细胞毒性。
Br J Cancer. 1999 Jun;80(8):1223-30. doi: 10.1038/sj.bjc.6690489.
2
Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.DT-黄递酶在癌症化学预防和化疗中的诱导作用。
Oncol Res. 1997;9(6-7):371-82.
3
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.功能基团对DT-黄递酶还原和激活醌类生物还原剂的影响。
Cancer Chemother Pharmacol. 2002 Feb;49(2):101-10. doi: 10.1007/s00280-001-0395-1. Epub 2001 Nov 24.
4
[DT-diaphorase].[DT-黄递酶]
Gan To Kagaku Ryoho. 1997 Sep;24(11):1606-10.
5
Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents.1,2-二硫醇-3-硫酮对人肿瘤细胞和正常细胞中DT-黄递酶的诱导作用及其对生物还原药物抗肿瘤活性的影响。
Br J Cancer. 1998 Apr;77(8):1241-52. doi: 10.1038/bjc.1998.209.
6
The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.DT-黄递酶在人结肠癌细胞系对丝裂霉素C耐药中的重要性。
J Surg Res. 1998 Dec;80(2):177-81. doi: 10.1006/jsre.1998.5481.
7
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.DT-黄递酶和细胞色素P450还原酶的表达与人类膀胱肿瘤中丝裂霉素C的活性相关。
Clin Cancer Res. 2001 May;7(5):1313-9.
8
DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.DT-黄递酶作为丝裂霉素C生化调节的靶酶
Hiroshima J Med Sci. 1995 Sep;44(3):55-63.
9
DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.DT-黄递酶作为人结肠和胃癌细胞系对丝裂霉素C敏感性的关键决定因素。
Cancer Res. 1996 Jun 15;56(12):2823-6.
10
[Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].[丝裂霉素C及其生物还原作用:NAD(P)H:醌氧化还原酶活性与丝裂霉素C诱导的DNA损伤和细胞毒性的相关性]
Gan To Kagaku Ryoho. 1993 Jun;20(8):1037-41.

引用本文的文献

1
The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder Cancer.饮食中的异硫氰酸盐对丝裂霉素C和卡介苗治疗非肌层浸润性膀胱癌疗效的影响
J Urol. 2024 Sep;212(3):420-430. doi: 10.1097/JU.0000000000004070. Epub 2024 Jun 7.
2
Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.细胞类型去卷积分析确定癌症相关肌成纤维细胞成分是多种癌症类型的不良预后因素。
Oncogene. 2021 Jul;40(28):4686-4694. doi: 10.1038/s41388-021-01870-x. Epub 2021 Jun 17.
3
NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.NRF2 依赖性米托蒽醌的生物活化作为一种靶向人类癌症中 KEAP1-NRF2 通路激活的新策略。
Mol Cell Biol. 2021 Jan 25;41(2). doi: 10.1128/MCB.00473-20.
4
Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A.萝卜硫素预处理使人结肠癌细胞对生物还原抗癌前药PR-104A敏感。
PLoS One. 2016 Mar 7;11(3):e0150219. doi: 10.1371/journal.pone.0150219. eCollection 2016.
5
Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.丝裂霉素类生物碱:作用机制、生物合成、全合成及合成方法
Chem Rev. 2013 Aug 14;113(8):6816-63. doi: 10.1021/cr3001059. Epub 2013 May 8.
6
Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent.上调人前列腺素还原酶 1 可提高羟甲基戊二酰基辅酶 A 还原酶抑制剂类抗肿瘤药物的疗效。
J Pharmacol Exp Ther. 2012 Nov;343(2):426-33. doi: 10.1124/jpet.112.195768. Epub 2012 Aug 15.
7
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.烟酰胺腺嘌呤二核苷酸(NAD(P)H):醌氧化还原酶 1(NQO1)在抗肿瘤醌类药物的敏感性和耐药性中的作用。
Biochem Pharmacol. 2012 Apr 15;83(8):1033-40. doi: 10.1016/j.bcp.2011.12.017. Epub 2011 Dec 24.
8
Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells.鉴定完整硫代萝卜硫素处理的肺动脉内皮细胞中 NAD(P)H:醌氧化还原酶活性的阈值。
Free Radic Biol Med. 2011 Apr 15;50(8):953-62. doi: 10.1016/j.freeradbiomed.2011.01.009. Epub 2011 Jan 14.
9
NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.NQO1激活的吩噻嗪氧化还原循环剂用于癌细胞凋亡的靶向生物还原诱导。
Free Radic Biol Med. 2007 Jul 15;43(2):178-90. doi: 10.1016/j.freeradbiomed.2007.03.035. Epub 2007 Apr 10.
10
Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo.通过饮食诱导NQO1可增强丝裂霉素C在人结肠肿瘤体内的抗肿瘤活性。
Br J Cancer. 2004 Oct 18;91(8):1624-31. doi: 10.1038/sj.bjc.6602171.

本文引用的文献

1
Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer.化学敏感性试验在确定晚期胃癌合适化疗方案中的价值的进一步证据。
Anticancer Res. 1998 May-Jun;18(3B):1973-8.
2
Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents.1,2-二硫醇-3-硫酮对人肿瘤细胞和正常细胞中DT-黄递酶的诱导作用及其对生物还原药物抗肿瘤活性的影响。
Br J Cancer. 1998 Apr;77(8):1241-52. doi: 10.1038/bjc.1998.209.
3
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.新型生物还原药物替拉扎明与顺铂联合用于晚期非小细胞肺癌患者的II期研究。
Ann Oncol. 1997 Dec;8(12):1269-71. doi: 10.1023/a:1008219125746.
4
Bioreductive agents: a clinical update.生物还原剂:临床最新进展
Oncol Res. 1997;9(6-7):391-5.
5
Soy feeding induces phase II enzymes in rat tissues.大豆喂养可诱导大鼠组织中的Ⅱ相酶。
Nutr Cancer. 1997;28(3):270-5. doi: 10.1080/01635589709514587.
6
Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.膳食化学保护剂在大鼠肝脏中的作用机制:I 相和 II 相药物代谢酶的诱导及黄曲霉毒素 B1 的代谢
Carcinogenesis. 1997 Sep;18(9):1729-38. doi: 10.1093/carcin/18.9.1729.
7
DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours.人肺癌和乳腺癌中的DT-黄递酶和细胞色素B5还原酶
Br J Cancer. 1997;76(7):923-9. doi: 10.1038/bjc.1997.485.
8
Molecular targeting of mitomycin C chemotherapy.丝裂霉素C化疗的分子靶向
Int J Cancer. 1997 Aug 7;72(4):649-56. doi: 10.1002/(sici)1097-0215(19970807)72:4<649::aid-ijc17>3.0.co;2-6.
9
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma.替拉扎明联合顺铂治疗晚期恶性黑色素瘤的II期试验
Ann Oncol. 1997 Apr;8(4):363-7. doi: 10.1023/a:1008249232000.
10
Development and validation of a spectrophotometric assay for measuring the activity of NADH: cytochrome b5 reductase in human tumour cells.用于测定人肿瘤细胞中NADH:细胞色素b5还原酶活性的分光光度法检测方法的开发与验证。
Br J Cancer. 1996 Oct;74(8):1188-93. doi: 10.1038/bjc.1996.515.

用 DT-黄递酶诱导剂增强丝裂霉素 C 对人肿瘤细胞的细胞毒性。

Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.

作者信息

Wang X, Doherty G P, Leith M K, Curphey T J, Begleiter A

机构信息

Manitoba Institute of Cell Biology, Manitoba Cancer Treatment and Research Foundation and Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada.

出版信息

Br J Cancer. 1999 Jun;80(8):1223-30. doi: 10.1038/sj.bjc.6690489.

DOI:10.1038/sj.bjc.6690489
PMID:10376975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2362377/
Abstract

DT-diaphorase is a two-electron reducing enzyme that activates the bioreductive anti-tumour agent, mitomycin C (MMC). Cell lines having elevated levels of DT-diaphorase are generally more sensitive to MMC. We have shown that DT-diaphorase can be induced in human tumour cells by a number of compounds, including 1,2-dithiole-3-thione. In this study, we investigated whether induction of DT-diaphorase could enhance the cytotoxic activity of MMC in six human tumour cell lines representing four tumour types. DT-diaphorase was induced by many dietary inducers, including propyl gallate, dimethyl maleate, dimethyl fumarate and sulforaphane. The cytotoxicity of MMC was significantly increased in four tumour lines with the increase ranging from 1.4- to threefold. In contrast, MMC activity was not increased in SK-MEL-28 human melanoma cells and AGS human gastric cancer cells, cell lines that have high base levels of DT-diaphorase activity. Toxicity to normal human marrow cells was increased by 50% when MMC was combined with 1,2-dithiole-3-thione, but this increase was small in comparison with the threefold increase in cytotoxicity to tumour cells. This study demonstrates that induction of DT-diaphorase can increase the cytotoxic activity of MMC in human tumour cell lines, and suggests that it may be possible to use non-toxic inducers of DT-diaphorase to enhance the efficacy of bioreductive anti-tumour agents.

摘要

DT-黄递酶是一种双电子还原酶,可激活生物还原抗肿瘤药物丝裂霉素C(MMC)。DT-黄递酶水平升高的细胞系通常对MMC更敏感。我们已经表明,DT-黄递酶可被多种化合物诱导产生,包括1,2-二硫杂环戊烯-3-硫酮,在人肿瘤细胞中也能被诱导产生。在本研究中,我们调查了DT-黄递酶的诱导是否能增强MMC对代表四种肿瘤类型的六种人肿瘤细胞系的细胞毒活性。DT-黄递酶可被多种膳食诱导剂诱导产生,包括没食子酸丙酯、马来酸二甲酯、富马酸二甲酯和萝卜硫素。在四种肿瘤细胞系中,MMC的细胞毒性显著增加,增加幅度在1.4至3倍之间。相比之下,在DT-黄递酶活性基础水平较高的SK-MEL-28人黑色素瘤细胞和AGS人胃癌细胞系中,MMC活性并未增加。当MMC与1,2-二硫杂环戊烯-3-硫酮联合使用时,对正常人骨髓细胞的毒性增加了50%,但与对肿瘤细胞的细胞毒性增加三倍相比,这一增加幅度较小。本研究表明,DT-黄递酶的诱导可增加MMC在人肿瘤细胞系中的细胞毒活性,并表明使用无毒的DT-黄递酶诱导剂来增强生物还原抗肿瘤药物的疗效可能是可行的。